21-41991062-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001098402.2(ZBTB21):āc.3034A>Gā(p.Thr1012Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000486 in 1,591,504 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001098402.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZBTB21 | NM_001098402.2 | c.3034A>G | p.Thr1012Ala | missense_variant | 3/3 | ENST00000310826.10 | NP_001091872.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZBTB21 | ENST00000310826.10 | c.3034A>G | p.Thr1012Ala | missense_variant | 3/3 | 1 | NM_001098402.2 | ENSP00000308759.5 | ||
ZBTB21 | ENST00000398499.5 | c.3034A>G | p.Thr1012Ala | missense_variant | 4/4 | 1 | ENSP00000381512.1 | |||
ZBTB21 | ENST00000398511.3 | c.3034A>G | p.Thr1012Ala | missense_variant | 2/2 | 1 | ENSP00000381523.3 | |||
ZBTB21 | ENST00000398505.7 | c.2431A>G | p.Thr811Ala | missense_variant | 4/4 | 1 | ENSP00000381517.3 |
Frequencies
GnomAD3 genomes AF: 0.000619 AC: 94AN: 151878Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000698 AC: 164AN: 235046Hom.: 0 AF XY: 0.000779 AC XY: 99AN XY: 127044
GnomAD4 exome AF: 0.000473 AC: 681AN: 1439508Hom.: 3 Cov.: 29 AF XY: 0.000553 AC XY: 395AN XY: 714178
GnomAD4 genome AF: 0.000612 AC: 93AN: 151996Hom.: 0 Cov.: 33 AF XY: 0.000633 AC XY: 47AN XY: 74266
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at